Split History
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| PIRS Stock Split History |
| Preferred Stock Newsletter |
| PIRS Options Chain |
| Stock Message Boards |
Pieris Pharmaceuticals (PIRS) has 1 split in our PIRS split history database. The split for PIRS took place on April 23, 2024. This was a 1 for 80 reverse split, meaning for each 80 shares of PIRS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 12.5 share position following the split.
When a company such as Pieris Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the PIRS split history from start to finish, an original position size of 1000 shares would have turned into 12.5 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Pieris Pharmaceuticals shares, starting with a $10,000 purchase of PIRS, presented on a split-history-adjusted basis factoring in the complete PIRS split history.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 04/14/2015 | |
| End date: | 05/03/2024 | |
| Start price/share: | $280.00 | |
| End price/share: | $11.08 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -96.04% | |
| Average Annual Total Return: | -29.99% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $395.46 | |
| Years: | 9.06 | |
 |
| About Pieris Pharmaceuticals |
| Pieris Pharmaceuticals is a biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. Co.'s clinical pipeline includes elarekibep an inhaled IL-4Ra antagonist Anticalin protein to treat uncontrolled asthma, PRS-220, an inhaled CTGF antagonist to treat IPF and other forms for fibrotic lung disease, an immuno-oncology (IO) bispecific PRS-344/S095012 targeting PD-L1 and 4-1BB. Co. has intellectual property rights directed to various aspects of its Anticalin technology platform, allowing for the development and improvement of both its platform and drug candidates. Co.'s development plans focus on its clinical and preclinical programs. According to our PIRS split history records, Pieris Pharmaceuticals has had 1 split. |
| PIRS Split History Table | |
| Date | Ratio |
| 04/23/2024 | 1 for 80 |
| Healthcare Stock Splits |
| PIRS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
PKI Split History Also explore: PIRS shares outstanding history
|
Free PIRS Email Alerts:
PIRS Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.